4.7 Article

The Role of Notch3 in Cancer

Journal

ONCOLOGIST
Volume 23, Issue 8, Pages 900-911

Publisher

OXFORD UNIV PRESS
DOI: 10.1634/theoncologist.2017-0677

Keywords

Notch3; Cancer; Tumor; CADASIL

Categories

Ask authors/readers for more resources

The Notch family is a highly conserved gene group that regulates cell-cell interaction, embryogenesis, and tissue commitment. This review article focuses on the third Notch family subtype, Notch3. Regulation via Notch3 signaling was first implicated in vasculogenesis. However, more recent findings suggest that Notch3 signaling may play an important role in oncogenesis, tumor maintenance, and resistance to chemotherapy. Its role is mainly oncogenic, although in some cancers it appears to be tumor suppressive. Despite the wealth of published literature, it remains relatively underexplored and requires further research to shed more light on its role in cancer development, determine its tissue-specific function, and elaborate novel treatment strategies. Herein we summarize the role of Notch3 in cancer, possible mechanisms of its action, and current cancer treatment strategies targeting Notch3 signaling. Implications for PracticeThe Notch family is a highly conserved gene group that regulates cell-cell interaction, embryogenesis, and tissue commitment. This review summarizes the existing data on the third subtype of the Notch family, Notch3. The role of Notch3 in different types of cancers is discussed, as well as implications of its modification and new strategies to affect Notch3 signaling activity. This review article focuses on the Notch3 gene subtype, summarizing its role in cancer, possible mechanisms of its action, and current cancer treatment strategies targeting Notch3 signaling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Surgery

Racial disparities in the cost of surgical care for parathyroidectomy

Samuel Jang, Meagan Mandabach, Zviadi Aburjania, Courtney J. Balentine, Herbert Chen

JOURNAL OF SURGICAL RESEARCH (2018)

Article Oncology

Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland

Jong Jin Hyun, J. Bart Rose, Adnan A. Alseidi, Thomas R. Biehl, Scott Helton, David L. Coy, Richard A. Kozarek, Flavio G. Rocha

JOURNAL OF SURGICAL ONCOLOGY (2019)

Editorial Material Surgery

Preface

J. Bart Rose

SURGICAL CLINICS OF NORTH AMERICA (2019)

Article Surgery

A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor-guided antibody-drug conjugate: Perspectives on clinical response?

Brendon Herring, Jason Whitt, Tolulope Aweda, Jianfa Ou, Rachael Guenter, Suzanne Lapi, Joel Berry, Herbert Chen, Xiaoguang Liu, J. Bart Rose, Renata Jaskula-Sztul

SURGERY (2020)

Review Medicine, General & Internal

Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors

Bin Ren, J. Bart Rose, Yehe Liu, Renata Jaskular-Sztul, Carlo Contreras, Adam Beck, Herbert Chen

JOURNAL OF CLINICAL MEDICINE (2019)

Editorial Material Surgery

Is radical ever too radical?

J. Bart Rose

AMERICAN JOURNAL OF SURGERY (2020)

Article Oncology

Sustained Carbohydrate Antigen 19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

J. Bart Rose, Alicia M. Edwards, Flavio G. Rocha, Carolyn Clark, Adnan A. Alseidi, Thomas R. Biehl, Bruce S. Lin, Vincent J. Picozzi, W. Scott Helton

ONCOLOGIST (2020)

Review Oncology

Biochemical Predictors of Response to Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma

Seifeldin Awad, Ahmad M. Alkashash, Magi Amin, Samantha J. Baker, J. Bart Rose

FRONTIERS IN ONCOLOGY (2020)

Review Oncology

Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data

Francesco Giovinazzo, Fiammetta Soggiu, Jin-Young Jang, Eva Versteijne, Geertjan van Tienhoven, Casper H. van Eijck, Youngmin Han, Seong Ho Choi, Chang Moo Kang, Mark Zalupski, Hasham Ahmad, Sarah Yentz, Scott Helton, J. Bart Rose, Chie Takishita, Yuichi Nagakawa, Mohammad Abu Hilal

FRONTIERS IN ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Synthetic Makaluvamine Analogs Decrease c-Kit Expression and Are Cytotoxic to Neuroendocrine Tumor Cells

Zviadi Aburjania, Jason D. Whitt, Samuel Jang, Dwayaja H. Nadkarni, Herbert Chen, J. Bart Rose, Sadanandan E. Velu, Renata Jaskula-Sztul

MOLECULES (2020)

Article Oncology

Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance

Tyler R. McCaw, Evelyn Inga, Herbert Chen, Renata Jaskula-Sztul, Vikas Dudeja, James A. Bibb, Bin Ren, J. Bart Rose

Summary: Gamma secretase inhibitors (GSIs), originally developed as Alzheimer's therapies, have been repurposed as anticancer agents due to their ability to inhibit Notch receptor cleavage. Despite showing promise in preclinical models, GSIs have not demonstrated significant clinical benefit in most solid tumors. Further research is needed to address limitations in understanding GSI mechanisms and improve their efficacy in cancer treatment.

ONCOLOGIST (2021)

Article Surgery

Does health insurance protect against risk of financial catastrophe for pancreatic tumor care? A cost-based review of patients undergoing pancreatic resection at an academic institution

Juliet S. Okoroh, Lauren Weaver, Martin J. Heslin, Selwyn M. Vickers, Thomas N. Wang, J. Bart Rose, Sushanth Reddy

Summary: The study on patients undergoing pancreatic resection at an academic institution revealed that most patients had insurance and hospital bill adjustments, resulting in the majority of patients not facing catastrophic health expenditure risk exceeding 10% of their estimated median household income.

AMERICAN JOURNAL OF SURGERY (2021)

Review Endocrinology & Metabolism

Management of Gastrointestinal Neuroendocrine Tumors

Rongzhi Wang, Rui Zheng-Pywell, H. Alexander Chen, James A. Bibb, Herbert Chen, J. Bart Rose

CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2019)

Letter Surgery

Gallbladder Ejection Fraction and Biliary Scintigraphy In Reply to Richmond and Fanelli

Steven M. Strasberg, J. Bart Rose

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2018)

No Data Available